| Bosutinib | IC50 | 3.8 [1] |
| Staurosporine | IC50 | 9.7 [1] |
| Dasatinib | IC50 | 0.6 [1] |
| 1-Tert-butyl-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 500.0 [1] |
| 1-Tert-butyl-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | Ki | 500.0 [1] |
| 4-[(2,4-Dichlorophenyl)amino]-6,7-dimethoxy-3-quinolinecarbonitrile | IC50 | 30.0 [1] |
| Imatinib | IC50 | 25000.0 [1], 100000.0 [2] |
| Imatinib | Ki | 31000.0 [1] |
| Saracatinib | IC50 | 2.7 [1] |
| N-Benzyl-1-(2-chloro-2-phenylethyl)-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | Ki | 3700.0 [1] |
| (2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-Amino-3-(4-phosphonooxyphenyl)propanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoic acid | IC50 | 6500.0 [1] |
| 7-(2,6-Dichlorophenyl)-5-methyl-N-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-1,2,4-benzotriazin-3-amine | IC50 | 9.4 [1], 14.0 [2] |
| 7-(2,6-Dichlorophenyl)-5-methyl-N-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-1,2,4-benzotriazin-3-amine | Ki | 11.0 [1], 28.1 [2] |
| 7-(2,6-Dimethylphenyl)-5-methyl-N-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-1,2,4-benzotriazin-3-amine | IC50 | 6.4 [1], 6.8 [2], 7.0 [3] |
| 7-(2,6-Dimethylphenyl)-5-methyl-N-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-1,2,4-benzotriazin-3-amine | Ki | 7.0 [1] |
| 1-(2-Chloro-2-phenylethyl)-6-(methylthio)-N-phenethyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | Ki | 700.0 [1] |
| (4S)-4-[[(2S)-2-[[(2S)-2-Acetamido-3-(4-phosphonooxyphenyl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-[[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid | IC50 | 1.0 [1], 150.0 [2], 6000.0 [3] |
| 1-(2-Chloro-2-phenylethyl)-N-(3-chlorophenyl)-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | Ki | 600.0 [1], 700.0 [2], 720.0 [3], 794.33 [4] |
| N-Acetyl-O-phosphono-Tyr-Glu-Glu-Ile-Glu | IC50 | 500.0 [1], 1400.0 [2], 2000.0 [3], 2800.0 [4] |
| 7-(2-Chlorophenyl)-5-methyl-N-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-1,2,4-benzotriazin-3-amine | IC50 | 34.8 [1], 35.0 [2] |
| 7-(2-Chlorophenyl)-5-methyl-N-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-1,2,4-benzotriazin-3-amine | Ki | 35.0 [1] |
| 6,7-Dimethoxy-4-[(3,4,5-trimethoxyphenyl)amino]quinoline-3-carbonitrile | IC50 | 34.0 [1], 35.0 [2], 108.0 [3], 190.0 [4], 650.0 [5] |
| Phenyl dihydrogen phosphate | IC50 | 300000.0 [1], 2500000.0 [2], 3500000.0 [3], 5000000.0 [4] |
| N-Benzyl-1-(2-chloro-2-phenylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | Ki | 3000.0 [1], 3162.28 [2] |
| 4-Chloro-3-(5-methyl-3-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)benzo[e][1,2,4]triazin-7-yl)phenol | IC50 | 1.6 [1], 1.8 [2] |
| 4-Chloro-3-(5-methyl-3-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)benzo[e][1,2,4]triazin-7-yl)phenol | Ki | 1.3 [1] |
| N-Acetyl-N-[1-(1,1'-biphenyl-4-ylmethyl)-2-oxoazepan-3-YL]-O-phosphonotyrosinamide | IC50 | 9.0 [1], 9000.0 [2] |
| 3-[2-(2-Cyclopentyl-6-{[4-(dimethylphosphoryl)phenyl]amino}-9H-purin-9-YL)ethyl]phenol | IC50 | 0.45 [1], 0.9 [2] |
| 1-(2-Chloro-2-phenylethyl)-6-methylsulfanyl-N-phenylpyrazolo[3,4-d]pyrimidin-4-amine | Ki | 1200.0 [1], 1600.0 [2] |
| 1-(2-Chloro-2-phenylethyl)-6-(2-morpholin-4-ylethylsulfanyl)-N-phenylpyrazolo[3,4-d]pyrimidin-4-amine | Ki | 210.0 [1], 240.0 [2] |
| 2-((4-(4-Amino-5-(3-methoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)phenethyl)(methyl)amino)ethanol | IC50 | 31.62 [1], 160.0 [2], 200.0 [3] |
| 2-Formylphenyl dihydrogen phosphate | IC50 | 80000.0 [1], 200000.0 [2], 300000.0 [3] |
| 2-Formyl-6-methoxyphenyl dihydrogen phosphate | IC50 | 95000.0 [1], 900000.0 [2] |
| N-(2-Chloro-5-methoxyphenyl)-7-(3-morpholin-4-ylpropoxy)-5-(oxan-4-yloxy)quinazolin-4-amine | IC50 | 10.0 [1], 20.0 [2], 200.0 [3] |
| N-(2-Chloro-5-methoxyphenyl)-7-(3-morpholin-4-ylpropoxy)-5-propan-2-yloxyquinazolin-4-amine | IC50 | 40.0 [1], 150.0 [2], 180.0 [3] |
| N-(4-(2-(Diethylamino)ethoxy)phenyl)-7-(2,6-dimethylphenyl)-5-methylbenzo[e][1,2,4]triazin-3-amine | IC50 | 9.67 [1], 10.0 [2] |
| N-(3-(2-(Diethylamino)ethoxy)phenyl)-7-(2,6-dimethylphenyl)-5-methylbenzo[e][1,2,4]triazin-3-amine | IC50 | 10.0 [1], 10.2 [2] |
| 5-Methyl-7-phenyl-N-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)benzo[e][1,2,4]triazin-3-amine | IC50 | 340.0 [1], 341.0 [2] |
| 7-Phenylaminothieno[3,2-b]pyridine-6-carbonitrile 2 | IC50 | 34.0 [1], 1200.0 [2] |
| 7-Phenylaminothieno[3,2-b]pyridine-6-carbonitrile 3 | IC50 | 13.0 [1], 720.0 [2] |
| 7-Phenylaminothieno[3,2-b]pyridine-6-carbonitrile 4 | IC50 | 50.0 [1], 4000.0 [2] |
| 7-Phenylaminothieno[3,2-b]pyridine-6-carbonitrile 34 | IC50 | 7.2 [1], 430.0 [2] |
| 7-Phenylaminothieno[3,2-b]pyridine-6-carbonitrile 42 | IC50 | 25.0 [1], 2400.0 [2] |
| 7-Thienyl-3-quinolinecarbonitrile 14 | IC50 | 3.8 [1], 64.0 [2], 69.0 [3] |
| 4-(4-Chloro-5-methoxy-2-methylanilino)-7,8-dimethoxybenzo[g]quinoline-3-carbonitrile | IC50 | 1.4 [1], 210.0 [2] |
| T338C Src-IN-1 | IC50 | 150.0 [1], 207.0 [2], 424.0 [3], 5000.0 [4] |
| T338C Src-IN-2 | IC50 | 29.0 [1], 67.0 [2], 338.0 [3], 5000.0 [4] |
| N-[3-(4-Amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)phenyl]ethenesulfonamide | IC50 | 63.0 [1], 111.0 [2], 131.0 [3], 1004.0 [4] |
| Genistein | IC50 | 10000.0 [1], 75000.0 [2], 100000.0 [3] |
| Su6656 | IC50 | 73.0 [1], 280.0 [2], 688000.0 [3] |
| 1-(Tert-Butyl)-3-(p-tolyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 5.0 [1], 17.0 [2], 170.0 [3] |
| N-Benzyl-2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)acetamide | IC50 | 20.0 [1], 20000.0 [2], 40000.0 [3] |
| Unii-NA856793UT | IC50 | 50000.0 [1] |
| 7-[cis-4-(4-Methylpiperazin-1-Yl)cyclohexyl]-5-(4-Phenoxyphenyl)-7h-Pyrrolo[2,3-D]pyrimidin-4-Amine | IC50 | 42.0 [1], 1190.0 [2] |
| Phenylmalonic acid | IC50 | 200000.0 [1], 2500000.0 [2], 2530000000.0 [3] |
| 1-Cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 14.0 [1] |
| CID 11973736 | IC50 | 10000.0 [1] |
| Ac-pTyr-Glu-Glu-Ile | IC50 | 9.0 [1], 150.0 [2], 6500.0 [3] |
| 2-Aminopyrido[2,3-d]pyrimidin-7(8H)-one 38 | IC50 | 16.0 [1], 17.0 [2], 20.0 [3] |
| N-Butyl-1-(2-chloro-2-phenyl-ethyl)-6-methylsulfanyl-pyrazolo[3,4-d]pyrimidin-4-amine | Ki | 1700.0 [1], 1995.26 [2] |
| N-Butyl-1-(2-chloro-2-phenyl-ethyl)-6-ethylsulfanyl-pyrazolo[3,4-d]pyrimidin-4-amine | Ki | 600.0 [1], 630.96 [2] |
| 1-[2-Amino-6-(2,6-dichlorophenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea | IC50 | 220.0 [1] |
| 1-(2-Chloro-2-phenyl-ethyl)-6-methylsulfanyl-N-propyl-pyrazolo[3,4-d]pyrimidin-4-amine | Ki | 794.33 [1], 2900.0 [2] |
| 1-(2-Chloro-2-phenylethyl)-6-(methylthio)-4-(piperidin-1-yl)-1H-pyrazolo[3,4-d]pyrimidine | Ki | 2400.0 [1], 2511.89 [2] |
| 4-(1-(2-Chloro-2-phenylethyl)-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)morpholine | Ki | 6309.57 [1], 6500.0 [2] |
| Bcr-abl Inhibitor II | Ki | 354.0 [1], 550.0 [2] |
| 1-(2-Chloro-2-phenylethyl)-N,N-diethyl-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | Ki | 500.0 [1], 501.19 [2] |
| N-(2-Fluorobenzyl)-1-(2-chloro-2-phenylethyl)-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | Ki | 21000.0 [1], 21200.0 [2] |
| N-(3-Chlorophenyl)-1-(2-chloro-2-phenylethyl)-6-(2-morpholin-4-ylethylsulfanyl)pyrazolo[3,4-d]pyrimidin-4-amine | Ki | 190.0 [1], 290.0 [2] |
| 2-(4-(Phenethylamino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-1-phenylethanol | Ki | 2400.0 [1], 2511.89 [2] |
| N-(4-Fluorobenzyl)-1-(2-chloro-2-phenylethyl)-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | Ki | 4600.0 [1] |
| 5,7-Diphenyl-4-aminopyrrolo[2,3-d]pyrimidine | IC50 | 100.0 [1], 3500.0 [2] |
| alpha-Sulfophenylacetic acid | IC50 | 192000.0 [1], 3200000.0 [2], 3230000000.0 [3] |
| 2-[4-[(2S)-2-Acetamido-3-oxo-3-[[(3S)-2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]propyl]-2-carboxyphenyl]propanedioic acid | IC50 | 3.0 [1], 5.0 [2] |
| CID 447524 | IC50 | 450.0 [1] |
| 1-[2-Chloro-2-(4-fluorophenyl)ethyl]-N-(3-fluorophenyl)pyrazolo[3,4-d]pyrimidin-4-amine | Ki | 100.0 [1], 160.0 [2] |
| N-Acetyl-N-[1-(1,1'-biphenyl-4-ylmethyl)-2-oxoazepan-3-YL]-3-formyl-O-phosphonotyrosinamide | IC50 | 0.25 [1] |
| 4-Phenylamino-3-quinolinecarbonitrile deriv. 25 | IC50 | 3.8 [1], 940.0 [2] |
| N-(3-Bromophenyl)-6-methylsulfanyl-1-(2-phenylpropyl)pyrazolo[3,4-d]pyrimidin-4-amine | Ki | 18.0 [1], 20.0 [2] |
| 4-Methyl-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | IC50 | 100000.0 [1] |
| 2-[4-[4-Amino-5-(3-methoxyphenyl)pyrrolo[2,3-d]pyrimidin-7-yl]phenyl]-N-(2-hydroxyethyl)acetamide | IC50 | 19.95 [1], 3900.0 [2] |
| 2-[3-(4-Amino-5-phenyl-pyrrolo[2,3-d]pyrimidin-7-yl)-benzylamino]-ethanol | IC50 | 10.0 [1], 4000.0 [2] |
| N-[3-(4-Pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | IC50 | 15700.0 [1] |
| 4-Chloro-3-(5-methyl-3-(4-(piperidin-4-ylsulfonyl)phenylamino)benzo[e][1,2,4]triazin-7-yl)phenol | IC50 | 5.2 [1] |
| 4-[[7-(2-Chloro-5-hydroxyphenyl)-5-methyl-1,2,4-benzotriazin-3-yl]amino]-N-(2-pyrrolidin-1-ylethyl)benzenesulfonamide | IC50 | 3.6 [1] |
| 4-[[7-(2-Chloro-6-hydroxyphenyl)-5-methyl-1,2,4-benzotriazin-3-yl]amino]-N-(2-pyrrolidin-1-ylethyl)benzenesulfonamide | IC50 | 12.6 [1], 13.0 [2] |
| 5-(3-Methoxyphenyl)-7-phenyl-4-aminopyrrolo[2,3-d]pyrimidine | IC50 | 50.12 [1], 3300.0 [2] |
| 2-(4-(4-Amino-5-(3-methoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)phenyl)ethanol | IC50 | 100.0 [1], 1150.0 [2] |
| (3-(4-Amino-5-phenyl-7H-pyrrolo[2,3-d]pyrimidin-7-yl)phenyl)methanol | IC50 | 63.1 [1], 5000.0 [2] |
| 2-(4-(4-Amino-5-(3-methoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)benzylamino)ethanol | IC50 | 31.62 [1], 500.0 [2] |
| 2-(4-(4-Amino-5-phenyl-7H-pyrrolo[2,3-d]pyrimidin-7-yl)benzylamino)ethanol | IC50 | 31.62 [1], 700.0 [2] |
| 4-[[7-(5-Amino-2-chlorophenyl)-5-methyl-1,2,4-benzotriazin-3-yl]amino]-N-(2-pyrrolidin-1-ylethyl)benzenesulfonamide | IC50 | 51.0 [1] |
| 4-Chloro-3-(5-methyl-3-{[4-(piperazin-1-ylcarbonyl)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenol | IC50 | 3.6 [1] |
| Phosphoric acid 3-formylphenyl ester | IC50 | 600000.0 [1], 2100000.0 [2], 2400000.0 [3] |
| N-[2-Phenyl-4-(1h-Pyrazol-3-Ylamino)quinazolin-7-Yl]prop-2-Enamide | IC50 | 43.0 [1], 65.0 [2], 211.0 [3] |
| 2,6-Diformyl-4-methylphenyl dihydrogen phosphate | IC50 | 39000.0 [1], 500000.0 [2] |
| 4-Phenylamino-3-quinolinecarbonitrile deriv. 26 | IC50 | 8.7 [1], 1000.0 [2] |
| 4-Phenylamino-3-quinolinecarbonitrile deriv. 1i | IC50 | 4.0 [1], 2400.0 [2] |
| 1-(2-Amino-6-phenylpyrido[2,3-d]pyrimidin-7-yl)-3-tert-butylurea | IC50 | 19330.0 [1], 50000.0 [2] |
| Chlorobenzodioxole deriv. 27 | IC50 | 5.0 [1], 120.0 [2] |